45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
2,303
Insurances with rates
18
CPT / HCPCS codes
2,238
Most expensive procedures (gross)
J2350
$86,499
Ocrelizumab 300 Mg/10 Ml
Gross
$89,174
J2350
$86,499
Ocrelizumab 300 Mg/10 Ml
Gross
$89,174
J2329
$45,761
Ublituximab-Xiiy 150 Mg/6 Ml
Gross
$47,176
J2329
$45,761
Ublituximab-Xiiy 150 Mg/6 Ml
Gross
$47,176
J3380
$38,967
Vedolizumab 300 MG Vial
Gross
$40,171
J3380
$38,967
Vedolizumab 300 MG Vial
Gross
$40,171
J3101
$30,637
Tenecteplase 50 Mg/10 Ml Syrng
Gross
$31,584
J3101
$30,637
Tenecteplase 50 Mg/10 Ml Syrng
Gross
$31,584
J0717
$25,110
Certolizumab Pegol 400 Mg Kit
Gross
$25,886
J0717
$25,110
Certolizumab Pegol 400 Mg Kit
Gross
$25,886
J9271
$25,006
Pembrolizumab 100 MG/4 ML Vial
Gross
$25,779
J9271
$25,006
Pembrolizumab 100 MG/4 ML Vial
Gross
$25,779
J9312
$20,699
Rituximab 500 MG/50 ML Vial
Gross
$21,339
J9312
$20,699
Rituximab 500 MG/50 ML Vial
Gross
$21,339
J1306
$15,055
Inclisiran 284mg/1.5ml Syringe
Gross
$15,520
J1306
$15,055
Inclisiran 284mg/1.5ml Syringe
Gross
$15,520
J2182
$13,027
Mepolizumab 100 MG Vial
Gross
$13,430
J2182
$13,027
Mepolizumab 100 MG Vial
Gross
$13,430
J2426
$12,391
Paliperidone Palm 234MG/1.5ML
Gross
$12,774
J2426
$12,391
Paliperidone Palm 234MG/1.5ML
Gross
$12,774
J9202
$11,874
Goserelin 10.8 MG Implant
Gross
$12,241
J9202
$11,874
Goserelin 10.8 MG Implant
Gross
$12,241
J3111
$10,851
Romosozumab-AQQG 210 Mg/2.34Ml
Gross
$11,187
J3111
$10,851
Romosozumab-AQQG 210 Mg/2.34Ml
Gross
$11,187
Q5123
$10,823
Rituximab-Arrx 500 Mg/50 Ml Vl
Gross
$11,157
Q5123
$10,823
Rituximab-Arrx 500 Mg/50 Ml Vl
Gross
$11,157
10180
$10,581
I&D Postop Wound Complex
Gross
$10,908
10180
$10,581
I&D Postop Wound Complex
Gross
$10,908
15271
$10,196
Skin Substitute Graft 25 Sq CM
Gross
$10,511
15275
$10,196
Skin Substitute Graft 25 Sq CM
Gross
$10,511
15275
$10,196
Skin Substitute Graft 25 Sq CM
Gross
$10,511
15271
$10,196
Skin Substitute Graft 25 Sq CM
Gross
$10,511
J3247
$9,384
Secukinumab 125 Mg/5 Ml Vial
Gross
$9,674
J3247
$9,384
Secukinumab 125 Mg/5 Ml Vial
Gross
$9,674
J0349
$8,842
Rezafungin 200 Mg Vial
Gross
$9,115
J0349
$8,842
Rezafungin 200 Mg Vial
Gross
$9,115
Q5111
$8,657
Pegfilgrastim-Cbqv 6 Mg/0.6 Ml
Gross
$8,925
Q5111
$8,657
Pegfilgrastim-Cbqv 6 Mg/0.6 Ml
Gross
$8,925
J1602
$8,567
Golimumab 50 MG/4 ML Vial
Gross
$8,831
J1602
$8,567
Golimumab 50 MG/4 ML Vial
Gross
$8,831
J3032
$8,124
Eptinezumab-JJMR 100Mg/Ml Vial
Gross
$8,375
J3032
$8,124
Eptinezumab-JJMR 100Mg/Ml Vial
Gross
$8,375
Q5122
$7,662
Pegfilgrastim 6 Mg/0.6 Ml Syr
Gross
$7,899
Q5122
$7,662
Pegfilgrastim 6 Mg/0.6 Ml Syr
Gross
$7,899
J0897
$7,504
Denosumab 60 MG/ML Syringe
Gross
$7,735
J0897
$7,504
Denosumab 60 MG/ML Syringe
Gross
$7,735
74174
$6,773
CTA Abd&Pelv WWO Dye
Gross
$6,982
74174
$6,773
CTA Abd&Pelv WWO Dye
Gross
$6,982
J0129
$6,267
Abatacept 250 MG Vial
Gross
$6,460
J0129
$6,267
Abatacept 250 MG Vial
Gross
$6,460
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2350 | Ocrelizumab 300 Mg/10 Ml | $89,174 | $86,499 | — | — | 9 |
| J2350 | Ocrelizumab 300 Mg/10 Ml | $89,174 | $86,499 | — | — | 11 |
| J2329 | Ublituximab-Xiiy 150 Mg/6 Ml | $47,176 | $45,761 | — | — | 9 |
| J2329 | Ublituximab-Xiiy 150 Mg/6 Ml | $47,176 | $45,761 | — | — | 9 |
| J3380 | Vedolizumab 300 MG Vial | $40,171 | $38,967 | — | — | 9 |
| J3380 | Vedolizumab 300 MG Vial | $40,171 | $38,967 | — | — | 12 |
| J3101 | Tenecteplase 50 Mg/10 Ml Syrng | $31,584 | $30,637 | — | — | 9 |
| J3101 | Tenecteplase 50 Mg/10 Ml Syrng | $31,584 | $30,637 | — | — | 11 |
| J0717 | Certolizumab Pegol 400 Mg Kit | $25,886 | $25,110 | — | — | 9 |
| J0717 | Certolizumab Pegol 400 Mg Kit | $25,886 | $25,110 | — | — | 11 |
| J9271 | Pembrolizumab 100 MG/4 ML Vial | $25,779 | $25,006 | — | — | 9 |
| J9271 | Pembrolizumab 100 MG/4 ML Vial | $25,779 | $25,006 | — | — | 9 |
| J9312 | Rituximab 500 MG/50 ML Vial | $21,339 | $20,699 | — | — | 9 |
| J9312 | Rituximab 500 MG/50 ML Vial | $21,339 | $20,699 | — | — | 9 |
| J1306 | Inclisiran 284mg/1.5ml Syringe | $15,520 | $15,055 | — | — | 9 |
| J1306 | Inclisiran 284mg/1.5ml Syringe | $15,520 | $15,055 | — | — | 9 |
| J2182 | Mepolizumab 100 MG Vial | $13,430 | $13,027 | — | — | 9 |
| J2182 | Mepolizumab 100 MG Vial | $13,430 | $13,027 | — | — | 9 |
| J2426 | Paliperidone Palm 234MG/1.5ML | $12,774 | $12,391 | — | — | 9 |
| J2426 | Paliperidone Palm 234MG/1.5ML | $12,774 | $12,391 | — | — | 9 |
| J9202 | Goserelin 10.8 MG Implant | $12,241 | $11,874 | — | — | 9 |
| J9202 | Goserelin 10.8 MG Implant | $12,241 | $11,874 | — | — | 11 |
| J3111 | Romosozumab-AQQG 210 Mg/2.34Ml | $11,187 | $10,851 | — | — | 9 |
| J3111 | Romosozumab-AQQG 210 Mg/2.34Ml | $11,187 | $10,851 | — | — | 9 |
| Q5123 | Rituximab-Arrx 500 Mg/50 Ml Vl | $11,157 | $10,823 | — | — | 9 |
| Q5123 | Rituximab-Arrx 500 Mg/50 Ml Vl | $11,157 | $10,823 | — | — | 11 |
| 10180 | I&D Postop Wound Complex | $10,908 | $10,581 | — | — | 9 |
| 10180 | I&D Postop Wound Complex | $10,908 | $10,581 | — | — | 9 |
| 15271 | Skin Substitute Graft 25 Sq CM | $10,511 | $10,196 | — | — | 9 |
| 15275 | Skin Substitute Graft 25 Sq CM | $10,511 | $10,196 | — | — | 9 |
| 15275 | Skin Substitute Graft 25 Sq CM | $10,511 | $10,196 | — | — | 7 |
| 15271 | Skin Substitute Graft 25 Sq CM | $10,511 | $10,196 | — | — | 9 |
| J3247 | Secukinumab 125 Mg/5 Ml Vial | $9,674 | $9,384 | — | — | 9 |
| J3247 | Secukinumab 125 Mg/5 Ml Vial | $9,674 | $9,384 | — | — | 9 |
| J0349 | Rezafungin 200 Mg Vial | $9,115 | $8,842 | — | — | 9 |
| J0349 | Rezafungin 200 Mg Vial | $9,115 | $8,842 | — | — | 9 |
| Q5111 | Pegfilgrastim-Cbqv 6 Mg/0.6 Ml | $8,925 | $8,657 | — | — | 9 |
| Q5111 | Pegfilgrastim-Cbqv 6 Mg/0.6 Ml | $8,925 | $8,657 | — | — | 9 |
| J1602 | Golimumab 50 MG/4 ML Vial | $8,831 | $8,567 | — | — | 9 |
| J1602 | Golimumab 50 MG/4 ML Vial | $8,831 | $8,567 | — | — | 9 |
| J3032 | Eptinezumab-JJMR 100Mg/Ml Vial | $8,375 | $8,124 | — | — | 9 |
| J3032 | Eptinezumab-JJMR 100Mg/Ml Vial | $8,375 | $8,124 | — | — | 9 |
| Q5122 | Pegfilgrastim 6 Mg/0.6 Ml Syr | $7,899 | $7,662 | — | — | 9 |
| Q5122 | Pegfilgrastim 6 Mg/0.6 Ml Syr | $7,899 | $7,662 | — | — | 11 |
| J0897 | Denosumab 60 MG/ML Syringe | $7,735 | $7,504 | — | — | 9 |
| J0897 | Denosumab 60 MG/ML Syringe | $7,735 | $7,504 | — | — | 9 |
| 74174 | CTA Abd&Pelv WWO Dye | $6,982 | $6,773 | — | — | 9 |
| 74174 | CTA Abd&Pelv WWO Dye | $6,982 | $6,773 | — | — | 9 |
| J0129 | Abatacept 250 MG Vial | $6,460 | $6,267 | — | — | 9 |
| J0129 | Abatacept 250 MG Vial | $6,460 | $6,267 | — | — | 9 |
Showing top 50 of 2,303 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.